- Home
- PCB vs SMTI Comparison
PCB vs SMTI Comparison
Compare PCB & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- SMTI
- Stock Information
- Founded
- PCB 2003
- SMTI 1982
- Country
- PCB United States
- SMTI United States
- Employees
- PCB N/A
- SMTI N/A
- Industry
- PCB Major Banks
- SMTI Medical/Dental Instruments
- Sector
- PCB Finance
- SMTI Health Care
- Exchange
- PCB Nasdaq
- SMTI Nasdaq
- Market Cap
- PCB 285.3M
- SMTI 288.2M
- IPO Year
- PCB N/A
- SMTI N/A
- Fundamental
- Price
- PCB $20.21
- SMTI $34.94
- Analyst Decision
- PCB Hold
- SMTI Strong Buy
- Analyst Count
- PCB 2
- SMTI 2
- Target Price
- PCB $22.00
- SMTI $47.00
- AVG Volume (30 Days)
- PCB 28.3K
- SMTI 32.2K
- Earning Date
- PCB 01-23-2025
- SMTI 11-12-2024
- Dividend Yield
- PCB 3.56%
- SMTI N/A
- EPS Growth
- PCB N/A
- SMTI N/A
- EPS
- PCB 1.68
- SMTI N/A
- Revenue
- PCB $94,833,000.00
- SMTI $78,056,873.00
- Revenue This Year
- PCB N/A
- SMTI $29.95
- Revenue Next Year
- PCB $10.34
- SMTI $19.68
- P/E Ratio
- PCB $12.04
- SMTI N/A
- Revenue Growth
- PCB N/A
- SMTI 24.66
- 52 Week Low
- PCB $14.50
- SMTI $26.00
- 52 Week High
- PCB $22.20
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- PCB 41.74
- SMTI 51.01
- Support Level
- PCB $19.09
- SMTI $31.13
- Resistance Level
- PCB $20.63
- SMTI $35.08
- Average True Range (ATR)
- PCB 0.60
- SMTI 1.89
- MACD
- PCB -0.25
- SMTI -0.23
- Stochastic Oscillator
- PCB 36.01
- SMTI 59.81
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.